- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Park pursues new high-energy technique
Park Medical earned a reputation as a pioneer in digital gammacamera design when it entered the market in 1993 with its Isocamline of systems. This year, the Lachine, Quebec, vendor intendsto reinforce its stature as an engineering innovator with a
Park Medical earned a reputation as a pioneer in digital gammacamera design when it entered the market in 1993 with its Isocamline of systems. This year, the Lachine, Quebec, vendor intendsto reinforce its stature as an engineering innovator with a radicallydifferent approach to high-energy radioisotope imaging.
With the rest of the industry embracing coincidence imagingof FDG-SPECT, Park has chosen to cast its lot with modified codedaperture technology (MCAT), according to CEO Richard Mullen. MCATwas developed by Dr. Harry Barratt at the University of Arizonain Tucson in the 1980s, but was set aside as impractical untilPark's chief scientist, Daniel Gagnon, took a second look at thetechnology.
The technique promises 10-fold improvement in sensitivity anda two-fold improvement in resolution over today's best gamma cameras,Mullen said. MCAT is less expensive than coincidence detectionand works with standard radiopharmaceutical and high-energy radioisotopes.Park will show phantom images produced with this investigationaltechnology.
The company will also feature a new infrared sensitivity contouringdevice available with its Isocam gamma cameras. Software enhancementson Park's Sun UltraSparc workstation will be emphasized as well.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
